Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)

CAPS Rating: 3 out of 5

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.

Results 1 - 20 of 44 : 1 2 3 Next »

Recs

0
Member Avatar OklaBoston (62.97) Submitted: 8/28/2015 5:23:36 PM : Underperform Start Price: $178.02 ALXN Score: +0.21

Toppy technicals in a stock I would pay no more than $30.00 to buy.

Recs

0
Member Avatar murphydevani (65.56) Submitted: 8/26/2015 1:15:53 AM : Underperform Start Price: $170.72 ALXN Score: -0.88

Target $163 - $161 - $160

Recs

0
Member Avatar marsuculix (60.25) Submitted: 8/25/2015 5:39:25 AM : Outperform Start Price: $171.82 ALXN Score: +1.96

PDUFA on Sep 8 of former GEVA drug sebelipase alfa - indication LAL deficiency under BTD...

Recs

0
Member Avatar TMFTypeoh (83.50) Submitted: 8/17/2015 2:30:36 PM : Outperform Start Price: $190.37 ALXN Score: -0.89

Expensive, but high quality.

Recs

0
Member Avatar jdkosmicki (35.26) Submitted: 7/2/2015 8:09:20 PM : Outperform Start Price: $183.24 ALXN Score: +0.58

Forward p/e of 14. Also, people get diseases no matter what happens in Greece.

Recs

0
Member Avatar andrewtraylor (38.79) Submitted: 4/16/2015 5:06:12 PM : Outperform Start Price: $182.00 ALXN Score: +2.71

Good ROE, profit margins and growth

Recs

0
Member Avatar Juggernaut0609 (91.51) Submitted: 4/1/2015 11:44:17 AM : Outperform Start Price: $168.26 ALXN Score: +9.01

Huge growth, no debt, lots of cash.

Recs

0
Member Avatar Defshark82 (61.79) Submitted: 12/31/2014 11:44:44 AM : Outperform Start Price: $187.71 ALXN Score: -0.62

Tracking JPM top pick

Recs

1
Member Avatar Tophinater (23.41) Submitted: 10/24/2014 10:13:29 AM : Outperform Start Price: $187.36 ALXN Score: -6.48

Sure, why not?

Recs

0
Member Avatar pchop123 (81.07) Submitted: 7/13/2014 6:55:12 PM : Outperform Start Price: $164.32 ALXN Score: +7.63

upside in price very likely

Recs

1
Member Avatar BigFatBEAR (29.25) Submitted: 7/9/2014 4:22:34 PM : Outperform Start Price: $161.62 ALXN Score: +8.19

Too rich for my real cash at this level, but loved enough by informed folks, such as zzlangerhans, to make me a watcher. Low beta, which could be quite handy in a selloff, but I'm guessing this thing will kiss $100 someday in the next year or two, what with biotech being volatile and all.

Appears to be one of the best-of-breed in the sector, so if you're going to own individual stocks instead of IBB, might as well go this route.

Recs

0
Member Avatar SnowBawl (< 20) Submitted: 5/5/2014 9:35:59 AM : Outperform Start Price: $155.11 ALXN Score: +8.23

13 classic growth stocks (Sterman).

Recs

0
Member Avatar TerryFool (77.49) Submitted: 3/7/2014 10:51:40 AM : Outperform Start Price: $164.85 ALXN Score: +2.40

BUY@ 165 1YR EPS 130% 2YR EPS 200% TP 188

Recs

0
Member Avatar Dudeone (93.30) Submitted: 2/12/2014 6:35:18 PM : Outperform Start Price: $174.23 ALXN Score: -7.38

Soliris continuing to grow and good products in pipeline e.g. asfotase

Recs

0
Member Avatar billyw10 (< 20) Submitted: 1/3/2014 6:26:30 PM : Outperform Start Price: $131.66 ALXN Score: +26.17

orphan drug alxn

Recs

0
Member Avatar CarlosDK (20.54) Submitted: 1/10/2013 8:12:04 AM : Underperform Start Price: $100.68 ALXN Score: -40.24

expensive on all valuations

Recs

0
Member Avatar ayuddha (48.16) Submitted: 7/15/2012 5:18:50 PM : Outperform Start Price: $96.87 ALXN Score: +36.05

It was picked by www.hechtsoft.de Trade Alerts.

Recs

1
Member Avatar danrifenburgh (< 20) Submitted: 12/19/2011 1:25:55 PM : Outperform Start Price: $67.44 ALXN Score: +96.89

After a 60% run-up, this volatile stock seems due for a fall. TM P/E of 82.96 with expected earnings growth of 31.54% taking it to a forward P/E of 38.81 next year. ALXN also trades at a premium to S&P500 TTM P/E. The PEG stands at 2.24, this could suggest some overvaluation. The Price/Book is 11.62.

Recs

1
Member Avatar rannici (< 20) Submitted: 10/27/2011 9:24:45 AM : Outperform Start Price: $67.84 ALXN Score: +103.59

just following the trend...

Recs

1
Member Avatar tradingblues1 (72.30) Submitted: 10/13/2011 7:05:08 PM : Outperform Start Price: $68.08 ALXN Score: +95.62

soaring to the moon!!

Results 1 - 20 of 44 : 1 2 3 Next »

Featured Broker Partners


Advertisement